▶ Freely access a vast video library on NASH and NAFLD, its management and diagnosis along with the latest on pan-PPAR agonist, lanifibranor.
Nash Videos

Prof Szabo Discusses the Progresses of the Quest of Biomarkers in NASH
Discover the progresses of the quest for biomarkers in NASH with Prof Szabo
View More ⏩Prof Szabo Discusses the Progresses of the Quest of Biomarkers in NASH
An insight into the prevalence of NAFLD and NASH. Prof Abdelmalek, USA
Prevalence of NAFLD (non-alcoholic fatty liver disease) affects…

What are the current definitions ? Prof Abdelmalek, USA
So NAFLD (non-alcoholic fatty liver disease) is a…

Learn more about the burden of the disease, Prof Sven Francque, Belgium
June 12 is dedicated to increasing awareness about non-alcoholic steatohepatitis, or NASH, among various populations: the general public, at-risk patients, the medical community, public health authorities, and the media.
View More ⏩Learn more about the burden of the disease, Prof Sven Francque, Belgium
Is NASH only about the liver ?
Prof Jean-François Dufour, Switzerland sheds lights on this important question.
View More ⏩Is NASH only about the liver ?
Prof Pierre-Emmanuel Rautou, Paris, France highlights two important abstracts
Prof Pierre-Emmanuel Rautou, Paris, France highlights two important abstracts presented in Boston during the Liver meeting 2019.
View More ⏩Prof Pierre-Emmanuel Rautou, Paris, France highlights two important abstracts